Journal Supplement: Increasing Clinical Trial Enrollment Among Adolescents with Cancer
Children with cancer are living much longer than they did 35 years ago. But 15- to 19-year-old teens have had less progress in survival compared to younger children, mostly because fewer older teens take part in clinical trials. CDC led a series of webinars to help address this problem. The articles in this Pediatrics journal supplement discuss the challenges of clinical trial enrollment among teens with cancer and offer recommendations to address this issue.
- Clinical trial enrollment among adolescents with cancer: supplement overview.
- Treatment setting, clinical trial enrollment, and subsequent outcomes among adolescents with cancer: a literature review.
- Understanding and addressing the lack of clinical trial enrollment among adolescents with cancer.
- Influencing referral of adolescents and young adults with cancer to sites with higher rates of trial enrollment.
- Improving enrollment in clinical trials for adolescents with cancer.
- Increasing the number of clinical trials available to adolescents diagnosed with cancer.
- Regulatory barriers to clinical trial enrollment of adolescent and young adult oncology patients.
- Psychosocial barriers and facilitators to clinical trial enrollment and adherence for adolescents with cancer.
- Centers for Disease Control and Prevention
Division of Cancer Prevention and Control
c/o CDC Warehouse
3719 N Peachtree Rd
Building 100 MS F-76
Chamblee GA 30341
TTY: (888) 232-6348
- Contact CDC-INFO